CHARLES MURPHY: Open Payments
NPI 1477723211 · VENTURA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 44 payments from 13 companies in 2025. Trend: 2023 $474 · 2024 $686 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $180 |
| AstraZeneca Pharmaceuticals LP | 9 | $139 |
| Alnylam Pharmaceuticals Inc. | 1 | $139 |
| Lilly USA, LLC | 3 | $80 |
| Novo Nordisk Inc | 3 | $71 |
| ABBVIE INC. | 3 | $65 |
| Exact Sciences Corporation | 2 | $51 |
| Eisai Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $22 |
| Cranial Technologies, Inc | 1 | $21 |
Products named: AMVUTTRA, OTEZLA, AIRSUPRA, MOUNJARO, FARXIGA, Cologuard Collection Kit, EVENITY, VRAYLAR.
Industry payments across CA — which companies pay providers there.
